SCHEMBL6154912

SCHEMBL6154912

CCc1cccc(N(C)C(=N)Nc2cc3cccc(N)c3oc2=O)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 17/20 0.43
TP53 P04637 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AR P10275 1/20 0.36
CBR1 P16152 1/20 0.36
AKR1C3 P42330 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424257 0.78 ALDH1A1 (0.40) MEN1LMNAKMT2AKDM4EALDH1A1
SCHEMBL6719963 0.78 SIGMAR1 (0.45) SIGMAR1TP53CYP2D6TSHRTHPO
Hydrochloric Acid SCHEMBL7411638 0.78 SIGMAR1 (0.44) SIGMAR1TP53CYP2D6TSHRTHPO
SCHEMBL6154897 0.75 SIGMAR1 (0.42) SIGMAR1TP53CYP2D6TSHRTHPO
Aptiganel SCHEMBL29742194 0.75 SIGMAR1 (0.62) SIGMAR1TP53CYP2D6TSHRTHPO
Aptiganel SCHEMBL151144 0.75 SIGMAR1 (0.62) SIGMAR1TP53CYP2D6TSHRTHPO
Aptiganel SCHEMBL7621534 0.74 SIGMAR1 (0.58) SIGMAR1TP53CYP2D6TSHRTHPO
Aptiganel SCHEMBL871689 0.74 SIGMAR1 (0.60) SIGMAR1TP53CYP2D6TSHRTHPO
Aptiganel SCHEMBL29430152 0.74 SIGMAR1 (0.60) SIGMAR1TP53CYP2D6TSHRTHPO
SCHEMBL929374 0.72 KDM4E (0.62) MEN1LMNAMAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0940139-B1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers SCION PHARMACEUTICALS INC (US) 2005-02-02 EP disclosed
EP-0940139-A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1999-09-08 EP disclosed